New findings and data obtained in the pathophysiology of IBS had promoting role in the revision of pharmacotherapy of IBS and they were crucial to stimulate the development of new classes of drugs. Symptom- specific treatment is based on three groups of drugs: products modifying the gastrointestinal smooth muscle activity, the visceral hypersensitivity and the central modulatory processes. Only small group of products fulfill the new evaluation criteria.
|Translated title of the contribution||New approaches in the pharmacotherapy of irritable bowel syndrome|
|Number of pages||4|
|Journal||Lege Artis Medicinae|
|Publication status||Published - Jun 20 2000|
ASJC Scopus subject areas